Group 1 - Concentra Group (CON) has gained approximately 15.8% year-to-date, outperforming the average return of 6.3% for the Medical sector [4] - The Zacks Rank for Concentra Group is currently 2 (Buy), indicating a positive outlook based on earnings estimates and revisions [3] - The Zacks Consensus Estimate for CON's full-year earnings has increased by 5.4% over the past quarter, reflecting stronger analyst sentiment [3] Group 2 - Concentra Group is part of the Medical Services industry, which consists of 59 companies and currently ranks 84 in the Zacks Industry Rank [5] - The Medical Services industry has seen an average gain of 4.3% year-to-date, indicating that Concentra Group is performing better than its industry peers [5] - Another stock in the Medical sector, Cencora (COR), has also outperformed the sector with a year-to-date return of 11.6% [4]